Cancer patients missing out on best treatment because of cost
Cancer patients are missing out on high-tech radiotherapy because the NHS is struggling to invest in staff and technology.Intensity modulated radiotherapy, which has been used in Europe and the US for a decade, is used to treat only 7 per cent of eligible NHS patients, according to research by the radiotherapy development board and national cancer action team.
Subscriber only content
You must be a paid subscriber to Health Service Journal magazine to read this article and receive complete, unrestricted access to hsj.co.uk
HSJ Subscribers:
If you are a Health Service Journal subscriber please sign in with your email address and click submit:
Not a HSJ subscriber?
Choose one of these options:
Subscribe today for immediate access to hsj.co.uk and Health Service Journal magazine
Find out more about the benefits of a subscription to HSJ by clicking below, or view a sample issue here
